229 related articles for article (PubMed ID: 30894570)
21. PGE
Lin MC; Chen SY; Tsai HM; He PL; Lin YC; Herschman H; Li HJ
Stem Cells; 2017 Feb; 35(2):425-444. PubMed ID: 27506158
[TBL] [Abstract][Full Text] [Related]
22. Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells.
Chae IG; Kim DH; Kundu J; Jeong CH; Kundu JK; Chun KS
Free Radic Res; 2014 Nov; 48(11):1311-21. PubMed ID: 25096910
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between the COX2-PGE2-EP4 signaling pathway and primary cilia in osteoblasts after mechanical stimulation.
Li YH; Zhu D; Yang T; Cheng L; Sun J; Tan L
J Cell Physiol; 2021 Jun; 236(6):4764-4777. PubMed ID: 33275302
[TBL] [Abstract][Full Text] [Related]
24. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
[TBL] [Abstract][Full Text] [Related]
25. PGE2 released by primary sensory neurons modulates Toll-like receptor 4 activities through an EP4 receptor-dependent process.
Tse KH; Chow KBS; Wise H
J Neuroimmunol; 2016 Apr; 293():8-16. PubMed ID: 27049555
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
[TBL] [Abstract][Full Text] [Related]
27. The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells.
Chandramouli A; Mercado-Pimentel ME; Hutchinson A; Gibadulinová A; Olson ER; Dickinson S; Shañas R; Davenport J; Owens J; Bhattacharyya AK; Regan JW; Pastorekova S; Arumugam T; Logsdon CD; Nelson MA
Cancer Biol Ther; 2010 Nov; 10(10):1056-66. PubMed ID: 20890108
[TBL] [Abstract][Full Text] [Related]
28. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM
Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661
[TBL] [Abstract][Full Text] [Related]
29. Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue.
Tang EH; Cai Y; Wong CK; Rocha VZ; Sukhova GK; Shimizu K; Xuan G; Vanhoutte PM; Libby P; Xu A
J Lipid Res; 2015 Feb; 56(2):358-68. PubMed ID: 25510249
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor.
Aoudjit L; Potapov A; Takano T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1534-42. PubMed ID: 16396944
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells.
Hawcroft G; Ko CW; Hull MA
Oncogene; 2007 May; 26(21):3006-19. PubMed ID: 17130837
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of lysyl oxidase by prostaglandin E2 via EP2/EP4 receptors in human amnion fibroblasts: Implications for parturition.
Liu C; Zhu P; Wang W; Li W; Shu Q; Chen ZJ; Myatt L; Sun K
Mol Cell Endocrinol; 2016 Mar; 424():118-27. PubMed ID: 26826430
[TBL] [Abstract][Full Text] [Related]
33. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
Cherukuri DP; Chen XB; Goulet AC; Young RN; Han Y; Heimark RL; Regan JW; Meuillet E; Nelson MA
Exp Cell Res; 2007 Aug; 313(14):2969-79. PubMed ID: 17631291
[TBL] [Abstract][Full Text] [Related]
34. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas.
Wei J; Zhang J; Wang D; Cen B; Lang JD; DuBois RN
Cancer Prev Res (Phila); 2022 May; 15(5):285-296. PubMed ID: 35121582
[TBL] [Abstract][Full Text] [Related]
35. Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism.
Kim HN; Narayanan NK; Lasano S; Narayanan B
Anticancer Res; 2011 Dec; 31(12):4347-57. PubMed ID: 22199300
[TBL] [Abstract][Full Text] [Related]
36. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101
[TBL] [Abstract][Full Text] [Related]
37. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
[TBL] [Abstract][Full Text] [Related]
38. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
[TBL] [Abstract][Full Text] [Related]
39. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
[TBL] [Abstract][Full Text] [Related]
40. PGE(2) induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation.
Yang L; Junmin S; Hong Y; Shuodong W
Ann Hepatol; 2013; 12(3):479-86. PubMed ID: 23619266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
